Therapeutic Nuclear Drug Global Market Report 2024

Global Therapeutic Nuclear Drug Market Report 2024

Therapeutic Nuclear Drug Global Market Report 2024 – By Type (Radium-223, Lutetium-177, Iodine-131, Other Types), By Distribution Channel (Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes), By Application (Thyroid, Bone Metastasis, Lymphoma, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Name: Therapeutic Nuclear Drug Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Therapeutic Nuclear Drug Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Global Therapeutic Nuclear Drug Market Infographic

Proud Members Of

Therapeutic Nuclear Drug Market Definition

Therapeutic nuclear drugs refer to a type of medication that uses radioactive materials to target and treat diseases, particularly cancer. These drugs utilize targeted radiopharmaceuticals that bind to cancer cells, delivering a therapeutic dose of radiation directly to these cells to destroy them while minimizing damage to surrounding healthy tissue.

The main types of therapeutic nuclear drug are radium-223, lutetium-177, iodine-131, others. Radium-223 is a type of therapeutic nuclear drug used primarily to treat prostate cancer that has spread to the bones. These are distributed through various distribution channels such as hospitals, ambulatory surgical centers, and cancer research institutes, and are used in various applications such as thyroid, bone metastasis, lymphoma, and others.

Therapeutic Nuclear Drug Market Segmentation

The therapeutic nuclear drug market covered in this report is segmented –

1) By Type: Radium-223, Lutetium-177, Iodine-131, Other Types

2) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes

3) By Application: Thyroid, Bone Metastasis, Lymphoma, Other Applications

Global Therapeutic Nuclear Drug Market Size 2023 to 2028: Graph

Therapeutic Nuclear Drug Market Size 2024 And Growth Rate

The therapeutic nuclear drug market size has grown rapidly in recent years. It will grow from $1.69 billion in 2023 to $1.94 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing regulatory approvals, increasing use of patient-specific information, improving dosimetry techniques, increasing awareness of nuclear medicines and increasing investment in research and development activities.

Therapeutic Nuclear Drug Market Growth Forecast

The therapeutic nuclear drug market size is expected to see rapid growth in the next few years. It will grow to $3.36 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to the shift towards personalized medicine, the rising demand for healthcare infrastructure improvements, the growing geriatric population, the growing number of diagnostic imaging procedures, and the rise of personalized care delivery. Major trends in the forecast period include nanoparticle-based delivery systems, advancements in radionuclide therapy, hybrid imaging systems, radiopharmaceutical manufacturing and development of alpha-emitting radiopharmaceuticals, and integration of machine learning and artificial intelligence.

Book your 30 minutes free consultation with our research experts

Therapeutic Nuclear Drug Market Driver: Increasing Prevalence Of Cancer Is Driving The Growth Of The Therapeutic Nuclear Drug Market

The increasing prevalence of cancer is expected to propel the growth of the therapeutic nuclear drug market going forward. Cancer is a disease characterized by the uncontrolled growth and spread of abnormal cells. The prevalence of cancer is due to improved detection and diagnosis, lifestyle factors, environmental exposures, and genetic factors. Therapeutic nuclear drugs act as a valuable component in the arsenal against cancer, providing targeted and effective treatment options for patients by reducing tumor size, alleviating symptoms, and improving quality of life. For instance, in February 2024, according to the World Health Organization, a Switzerland-based agency of the United Nations, It is projected that over 35 million new cancer cases will arise by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the therapeutic nuclear drug market.

Global Therapeutic Nuclear Drug Market Major Players

Major companies operating in the therapeutic nuclear drug market are Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals

Global Therapeutic Nuclear Drug Market Trend: Strategic Partnerships Transforming The Therapeutic Nuclear Drug Market

Major companies operating in the therapeutic nuclear drug market are focused on forming strategic partnerships to gain a competitive edge in the market. These partnerships play an important role in enhancing research and development capabilities, accelerating the commercialization of new therapies, and expanding access to innovative treatments through shared resources and expertise. For instance, In July 2022, DeepC is a Germany-based software company, partnered with PAIRE, an US-based AI solutions provider, to enhance nuclear medicine diagnostics. With this partnership, they aim to enhance the precision and efficiency of nuclear medicine diagnostics by integrating PAIRE’s AI solution, Pionus, into DeepC's deepcOS platform for improved PET/CT scan interpretations.

Therapeutic Nuclear Drug Market Merger And Acquisition: Telix Pharmaceuticals Acquired QSAM Biosciences To Bolster Pipeline With Bone Metastases Drug

In May 2024, Telix Pharmaceuticals Limited, an Australia-based biotechnology company, acquired QSAM Biosciences for an undisclosed amount. Through this acquisition, Telix Pharmaceuticals aims to enhance its therapeutic pipeline with the investigational drug Samarium-153-DOTMP, which targets bone metastases and osteosarcoma. QSAM Biosciences is a US-based biotechnology company focused on developing next-generation nuclear therapeutic medicines.

Regional Insights For The Global Therapeutic Nuclear Drug Market

North America was the largest region in the therapeutic nuclear drug market in 2023. The regions covered in the therapeutic nuclear drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the therapeutic nuclear drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic nuclear drug market consists of sales of yttrium-90, actinium-225, bismuth-213, therapeutic iodine-123, and copper-67. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The therapeutic nuclear drugs market research report is one of a series of new reports from The Business Research Company that provides therapeutic nuclear drugs market statistics, including the therapeutic nuclear drugs industry global market size, regional shares, competitors with a therapeutic nuclear drugs market share, detailed therapeutic nuclear drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the therapeutic nuclear drugs industry. This therapeutic nuclear drug research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Therapeutic Nuclear Drug Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2024	$ 29.17 Billion
Revenue Forecast In 2033	$ 37.39 Billion
Growth Rate	CAGR of 6.40% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Type: Radium-223, Lutetium-177, Iodine-131, Other Types 2) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes 3) By Application: Thyroid, Bone Metastasis, Lymphoma, Other Applications
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Bayer AG, Novartis International AG, Siemens Healthineers AG, Ipsen S.A., Jubilant DraxImage Inc., Mallinckrodt Pharmaceuticals PLC, The Bracco Group, Lantheus Medical Imaging Inc., Piramal Group, Curium Pharmaceuticals, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Eckert & Ziegler, Telix Pharmaceuticals Limited, International Isotopes inc., Orano SA, Q BioMed Inc., Molecular Targeting Technologies Inc, Medi-Radiopharma Co. Ltd., Actinium Pharmaceuticals, Fusion Pharmaceuticals
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Therapeutic Nuclear Drug Market Characteristics

3. Therapeutic Nuclear Drug Market Trends And Strategies

4. Therapeutic Nuclear Drug Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Therapeutic Nuclear Drug Market Size and Growth

5.1. Global Therapeutic Nuclear Drug Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Therapeutic Nuclear Drug Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Therapeutic Nuclear Drug Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Therapeutic Nuclear Drug Market Segmentation

6.1. Global Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Radium-223

Lutetium-177

Iodine-131

Other Types

6.2. Global Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Ambulatory Surgical Centers (ASCs)

Cancer Research Institutes

6.3. Global Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Thyroid

Bone Metastasis

Lymphoma

Other Applications

7. Therapeutic Nuclear Drug Market Regional And Country Analysis

7.1. Global Therapeutic Nuclear Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Therapeutic Nuclear Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Therapeutic Nuclear Drug Market

8.1. Asia-Pacific Therapeutic Nuclear Drug Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Therapeutic Nuclear Drug Market

9.1. China Therapeutic Nuclear Drug Market Overview

9.2. China Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Therapeutic Nuclear Drug Market

10.1. India Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Therapeutic Nuclear Drug Market

11.1. Japan Therapeutic Nuclear Drug Market Overview

11.2. Japan Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Therapeutic Nuclear Drug Market

12.1. Australia Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Therapeutic Nuclear Drug Market

13.1. Indonesia Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Therapeutic Nuclear Drug Market

14.1. South Korea Therapeutic Nuclear Drug Market Overview

14.2. South Korea Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Therapeutic Nuclear Drug Market

15.1. Western Europe Therapeutic Nuclear Drug Market Overview

15.2. Western Europe Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Therapeutic Nuclear Drug Market

16.1. UK Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Therapeutic Nuclear Drug Market

17.1. Germany Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Therapeutic Nuclear Drug Market

18.1. France Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.2. France Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.3. France Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Therapeutic Nuclear Drug Market

19.1. Italy Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.2. Italy Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.3. Italy Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Therapeutic Nuclear Drug Market

20.1. Spain Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.2. Spain Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.3. Spain Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Therapeutic Nuclear Drug Market

21.1. Eastern Europe Therapeutic Nuclear Drug Market Overview

21.2. Eastern Europe Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Therapeutic Nuclear Drug Market

22.1. Russia Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Therapeutic Nuclear Drug Market

23.1. North America Therapeutic Nuclear Drug Market Overview

23.2. North America Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Therapeutic Nuclear Drug Market

24.1. USA Therapeutic Nuclear Drug Market Overview

24.2. USA Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Therapeutic Nuclear Drug Market

25.1. Canada Therapeutic Nuclear Drug Market Overview

25.2. Canada Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Therapeutic Nuclear Drug Market

26.1. South America Therapeutic Nuclear Drug Market Overview

26.2. South America Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Therapeutic Nuclear Drug Market

27.1. Brazil Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Therapeutic Nuclear Drug Market

28.1. Middle East Therapeutic Nuclear Drug Market Overview

28.2. Middle East Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Therapeutic Nuclear Drug Market

29.1. Africa Therapeutic Nuclear Drug Market Overview

29.2. Africa Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Therapeutic Nuclear Drug Market Competitive Landscape And Company Profiles

30.1. Therapeutic Nuclear Drug Market Competitive Landscape

30.2. Therapeutic Nuclear Drug Market Company Profiles

30.2.1. Bayer AG

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Novartis International AG

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Siemens Healthineers AG

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Ipsen S.A.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. Jubilant DraxImage Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Therapeutic Nuclear Drug Market Other Major And Innovative Companies

31.1. Mallinckrodt Pharmaceuticals PLC

31.2. The Bracco Group

31.3. Lantheus Medical Imaging Inc.

31.4. Piramal Group

31.5. Curium Pharmaceuticals

31.6. Yantai Dongcheng Pharmaceutical Group Co. Ltd.

31.7. Eckert & Ziegler

31.8. Telix Pharmaceuticals Limited

31.9. International Isotopes inc.

31.10. Orano SA

31.11. Q BioMed Inc.

31.12. Molecular Targeting Technologies Inc

31.13. Medi-Radiopharma Co. Ltd.

31.14. Actinium Pharmaceuticals

31.15. Fusion Pharmaceuticals

32. Global Therapeutic Nuclear Drug Market Competitive Benchmarking

33. Global Therapeutic Nuclear Drug Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Therapeutic Nuclear Drug Market

35. Therapeutic Nuclear Drug Market Future Outlook and Potential Analysis

35.1 Therapeutic Nuclear Drug Market In 2028 - Countries Offering Most New Opportunities

35.2 Therapeutic Nuclear Drug Market In 2028 - Segments Offering Most New Opportunities

35.3 Therapeutic Nuclear Drug Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Figure 1:

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Figure 3: Global Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 4: Global Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 5: Global Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 6: Global Therapeutic Nuclear Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 7: Global Therapeutic Nuclear Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 8: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 9: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 10: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 11: China, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 12: China, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 13: China, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 14: India, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 15: India, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 16: India, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 17: Japan, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 18: Japan, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 19: Japan, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 20: Australia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 21: Australia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 22: Australia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 23: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 24: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 25: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 26: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 27: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 28: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 29: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 30: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 31: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 32: UK, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 33: UK, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 34: UK, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 35: Germany, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 36: Germany, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 37: Germany, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 38: France, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 39: France, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 40: France, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 41: Italy, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 42: Italy, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 43: Italy, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 44: Spain, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 45: Spain, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 46: Spain, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 47: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 48: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 49: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 50: Russia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 51: Russia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 52: Russia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 53: North America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 54: North America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 55: North America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 56: USA, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 57: USA, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 58: USA, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 59: Canada, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 60: Canada, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 61: Canada, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 62: South America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 63: South America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 64: South America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 65: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 66: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 67: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 68: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 69: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 70: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 71: Africa, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 72: Africa, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 73: Africa, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Figure 74: Bayer AG Financial Performance
Figure 75: Novartis International AG Financial Performance
Figure 76: Siemens Healthineers AG Financial Performance
Figure 77: Ipsen S.A. Financial Performance
Figure 78: Jubilant DraxImage Inc. Financial Performance

List Of Figures

Table 1:

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 6: Global Therapeutic Nuclear Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 7: Global Therapeutic Nuclear Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 8: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 9: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 10: Asia-Pacific, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 11: China, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 12: China, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 13: China, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 14: India, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 15: India, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 16: India, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 17: Japan, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 18: Japan, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 19: Japan, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 20: Australia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 21: Australia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 22: Australia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 23: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 24: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 25: Indonesia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 26: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 27: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 28: South Korea, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 29: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 30: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 31: Western Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 32: UK, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 33: UK, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 34: UK, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 35: Germany, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 36: Germany, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 37: Germany, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 38: France, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 39: France, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 40: France, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 41: Italy, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 42: Italy, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 43: Italy, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 44: Spain, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 45: Spain, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 46: Spain, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 47: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 48: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 49: Eastern Europe, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 50: Russia, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 51: Russia, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 52: Russia, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 53: North America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 54: North America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 55: North America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 56: USA, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 57: USA, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 58: USA, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 59: Canada, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 60: Canada, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 61: Canada, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 62: South America, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 63: South America, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 64: South America, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 65: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 66: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 67: Brazil, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 68: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 69: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 70: Middle East, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 71: Africa, Therapeutic Nuclear Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 72: Africa, Therapeutic Nuclear Drug Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 73: Africa, Therapeutic Nuclear Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 74: Bayer AG Financial Performance
Table 75: Novartis International AG Financial Performance
Table 76: Siemens Healthineers AG Financial Performance
Table 77: Ipsen S.A. Financial Performance
Table 78: Jubilant DraxImage Inc. Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

The Microbiome Market Share, Market Size, And Growth Rate 2022

Latest TNF Alpha Inhibitors Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Drug Infusion Systems Global Market Report 2024 – By Product Type (Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System), By Route Of Administration (Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration), By Application (Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Thalassemia Drugs Global Market Report 2024 – By Type (Alpha Thalassemia Drugs, Beta Thalassemia Drugs), By Treatment Type (Iron Chelation Therapy, Other Treatments), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores And Retail Pharmacies) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Advanced Drug Delivery Systems Global Market Report 2024 – By Type (Oral Drug Delivery System, Injection-Based Drug Delivery System, Inhalation/Pulmonary Drug Delivery System, Transdermal Drug Delivery System, Transmucosal Drug Delivery System, Carrier-Based Drug Delivery System, Other Types), By Carrier Type (Liposomes, Nanoparticles, Microspheres, Monoclonal Antibodies, Other Carrier Types), By Technology (Prodrug, Implants And Intrauterine Devices, Targeted Drug Delivery, Polymeric Drug Delivery, Other Technologies), By Application (Cardiovascular Diseases, Oncology, Urology, Diabetes, CNS (Central Nervous System), Ophthalmology, Inflammatory Diseases, Infections, Other Applications), By End User (Hospitals, Specialized clinics, Clinical Research And Development Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drug Discovery Technologies Global Market Report 2024 – By Technology (High Throughput Screening, Genomics, Nanotechnology, Bioinformatics, Combinational Chemistry, Pharmacogenomics, Biochips, Bioanalytical Instruments, Ribonucleic Acid Interface (RNAI)), By Drug Type (Small Molecule Drugs, Biologic Drugs), By Disease Application (Cancer Diseases, Immunological Diseases, Neurological Diseases, Cardiovascular Diseases, Other Disease Applications), By End-User (Pharmaceutical Companies, Biopharmaceutical Companies, Biotechnology Companies, Research Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Multiple Sclerosis Drugs Global Market Report 2024 – By Drug Class (Immunomodulators, Immunosuppressants, Interferons, Other Drug Classes), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Stores), By Route Of Administration (Oral Drugs, Parenteral Drugs) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Acne Drugs Global Market Report 2024 – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Acid, Benzoyl Peroxide, Other Therapeutics), By End User (Hospitals & Clinics, Pharmacies & Drug Stores, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Sarcoma Drugs Global Market Report 2024 – By Treatment Type (Chemotherapy, Targeted Therapy), By Disease Indication (Malignant Bone Tumors, Soft Tissue Sarcomaz), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Drug Delivery Devices Global Market Report 2024 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the therapeutic nuclear drug market?

How will the therapeutic nuclear drug market drivers and restraints affect the therapeutic nuclear drug market dynamics? What forces will shape the therapeutic nuclear drug industry going forward?

The therapeutic nuclear drug market major growth driver - Increasing Prevalence Of Cancer Is Driving The Growth Of The Therapeutic Nuclear Drug Market. For further insights on the therapeutic nuclear drug market, request a sample here

What is the forecast market size or the forecast market value of the therapeutic nuclear drug market?

The therapeutic nuclear drug market size has grown rapidly in recent years. It will grow from $1.69 billion in 2023 to $1.94 billion in 2024 at a compound annual growth rate (CAGR) of 14.5%. The growth in the historic period can be attributed to increasing regulatory approvals, increasing use of patient-specific information, improving dosimetry techniques, increasing awareness of nuclear medicines and increasing investment in research and development activities. The therapeutic nuclear drug market size is expected to see rapid growth in the next few years. It will grow to $3.36 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to the shift towards personalized medicine, the rising demand for healthcare infrastructure improvements, the growing geriatric population, the growing number of diagnostic imaging procedures, and the rise of personalized care delivery. Major trends in the forecast period include nanoparticle-based delivery systems, advancements in radionuclide therapy, hybrid imaging systems, radiopharmaceutical manufacturing and development of alpha-emitting radiopharmaceuticals, and integration of machine learning and artificial intelligence. For further insights on the therapeutic nuclear drug market, request a sample here

How is the therapeutic nuclear drug market segmented?

The therapeutic nuclear drug market is segmented
1) By Type: Radium-223, Lutetium-177, Iodine-131, Other Types
2) By Distribution Channel: Hospitals, Ambulatory Surgical Centers (ASCs), Cancer Research Institutes
3) By Application: Thyroid, Bone Metastasis, Lymphoma, Other Applications For further insights on the therapeutic nuclear drug market, request a sample here

Which region has the largest share of the therapeutic nuclear drug market? What are the other regions covered in the report?

North America was the largest region in the therapeutic nuclear drug market in 2023. The regions covered in the therapeutic nuclear drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the therapeutic nuclear drug market, request a sample here.

Who are the major players in the therapeutic nuclear drug market?

What are the key trends in the therapeutic nuclear drug market?

Major trend in the therapeutic nuclear drug market - Strategic Partnerships Transforming The Therapeutic Nuclear Drug Market. For further insights on the therapeutic nuclear drug market, request a sample here.

What are the major opportunities in the therapeutic nuclear drug market? What are the strategies for the therapeutic nuclear drug market?

For detailed insights on the major opportunities and strategies in the therapeutic nuclear drug market, request a sample here.

How does the therapeutic nuclear drug market relate to the overall economy and other similar markets?

For detailed insights on therapeutic nuclear drug market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the therapeutic nuclear drug industry?

For detailed insights on the mergers and acquisitions in the therapeutic nuclear drug industry, request a sample here.

What are the key dynamics influencing the therapeutic nuclear drug market growth? SWOT analysis of the therapeutic nuclear drug market.

For detailed insights on the key dynamics influencing the therapeutic nuclear drug market growth and SWOT analysis of the therapeutic nuclear drug industry, request a sample here.